Skip to main content

School of Medicine

Helping Native Americans battle COVID-19: Tamee Livermont, MPH’20

Apr. 30, 2020—Tamee Livermont was eager to begin working as a public health liaison with the Great Plains Tribal Chairman’s Health Board even before completing her studies at Vanderbilt. But just a week after starting her new position, instead of shaping policy, she was directly involved with the fight against COVID-19.

Read more


Improving Care for Individuals with Physical Disabilities: Jonathan Dallas, MD’20

Apr. 30, 2020—Jonathan Dallas is many things: a graduating medical student, a promising neurosurgeon, a researcher, an advocate. He’s also an amputee.

Read more


‘U.S. News’ ranks Vanderbilt graduate schools among nation’s best

Apr. 14, 2020—"U.S. News & World Report" continues to place Vanderbilt University's graduate schools among the nation's best in its latest rankings.

Read more


Vanderbilt Health Policy COVID-19 model finds evidence of flattening curve, recommends distancing policies continue

Apr. 10, 2020—Vanderbilt researchers find that social distancing policies have slowed the spread of COVID-19, but caution that continued distancing is needed to keep the rate of spread low, and that any future rollback of such policies must be contingent on widely available testing and contact tracing.

Read more


Study aims to shield health workers from COVID-19 infection

Apr. 10, 2020—Vanderbilt University Medical Center is playing a key role in the HERO program, a national effort to establish a registry of U.S. health care workers and test whether the anti-malarial drug hydroxychloroquine will protect them, their patients and their families from COVID-19.

Read more


Study launched to test hydroxychloroquine as treatment for COVID-19

Apr. 10, 2020—Vanderbilt University Medical Center is leading a clinical trial to understand if a well-known drug used for malaria and rheumatologic conditions is safe and effective in treating hospitalized adults with COVID-19.

Read more


Vanderbilt University Medical Center and AstraZeneca join forces to identify potential COVID-19 treatments

Apr. 9, 2020—Vanderbilt University Medical Center and the global biopharmaceutical company AstraZeneca have joined forces to identify candidates for antibody-based treatments that could protect people exposed to the 2019 novel coronavirus disease, COVID-19.

Read more


‘COVID-19 Update Through a Public Health Lens’ featuring Dr. William Schaffner April 10

Apr. 6, 2020—Dr. William Schaffner, an internationally renowned infectious disease specialist and public health expert, will provide the latest updates on COVID-19 and answer questions from the audience.

Read more


Celebration honors nine new endowed chair holders

Feb. 28, 2020—Nine Vanderbilt faculty members who have been awarded endowed chairs were recently honored by Interim Chancellor and Provost Susan R. Wente, deans, colleagues and family members.

Read more


Flexner Deans’ Lecture March 9: 2020 VUSM Student Lecturers

Feb. 24, 2020—Marie Kuzemchak Patten and Samuel Trump will speak as part of the Vanderbilt University School of Medicine 2020 student lectures beginning at noon, Monday, March 23, in Light Hall, Room 208.

Read more


Stanley Cohen, Vanderbilt biochemist who won Nobel Prize, has died

Feb. 6, 2020—Stanley Cohen, a legendary Vanderbilt University biochemist who was awarded the Nobel Prize for the discovery of epidermal growth factor and its receptor, died on Feb. 5 at the age of 97.

Read more


Study links Medicaid expansion and recipients’ health status

Jan. 10, 2020—In Southern states that expanded their Medicaid programs under the Affordable Care Act, adults experienced lower rates of decline in both physical and mental health, according to a new Vanderbilt analysis.

Read more


VIEW MORE EVENTS >